KURA
Price
$5.81
Change
+$0.13 (+2.29%)
Updated
Jul 8 closing price
Capitalization
503M
22 days until earnings call
ZBIO
Price
$9.97
Change
+$0.18 (+1.84%)
Updated
Jul 8 closing price
Capitalization
417.09M
56 days until earnings call
Interact to see
Advertisement

KURA vs ZBIO

Header iconKURA vs ZBIO Comparison
Open Charts KURA vs ZBIOBanner chart's image
Kura Oncology
Price$5.81
Change+$0.13 (+2.29%)
Volume$965.71K
Capitalization503M
Zenas Biopharma
Price$9.97
Change+$0.18 (+1.84%)
Volume$163.22K
Capitalization417.09M
KURA vs ZBIO Comparison Chart in %
Loading...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KURA vs. ZBIO commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and ZBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (KURA: $5.81 vs. ZBIO: $9.97)
Brand notoriety: KURA and ZBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 75% vs. ZBIO: 91%
Market capitalization -- KURA: $503M vs. ZBIO: $417.09M
KURA [@Biotechnology] is valued at $503M. ZBIO’s [@Biotechnology] market capitalization is $417.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whileZBIO’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • ZBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both KURA and ZBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 3 TA indicator(s) are bullish while ZBIO’s TA Score has 4 bullish TA indicator(s).

  • KURA’s TA Score: 3 bullish, 6 bearish.
  • ZBIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZBIO is a better buy in the short-term than KURA.

Price Growth

KURA (@Biotechnology) experienced а +3.75% price change this week, while ZBIO (@Biotechnology) price change was +9.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

KURA is expected to report earnings on Oct 30, 2025.

ZBIO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($503M) has a higher market cap than ZBIO($417M). ZBIO YTD gains are higher at: 21.734 vs. KURA (-33.295). ZBIO (-173.51M) and KURA (-177.18M) have comparable annual earnings (EBITDA) . KURA has more cash in the bank: 658M vs. ZBIO (312M). ZBIO has less debt than KURA: ZBIO (1.23M) vs KURA (19.4M). KURA has higher revenues than ZBIO: KURA (68M) vs ZBIO (15M).
KURAZBIOKURA / ZBIO
Capitalization503M417M121%
EBITDA-177.18M-173.51M102%
Gain YTD-33.29521.734-153%
P/E RatioN/AN/A-
Revenue68M15M453%
Total Cash658M312M211%
Total Debt19.4M1.23M1,584%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KURAZBIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 15 days ago
89%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DREYX41.530.06
+0.14%
Davis Real Estate Y
FBTCX20.46N/A
N/A
Fidelity Advisor Biotechnology C
ACSCX9.81N/A
N/A
American Century Small Cap Value A
PRNCX11.14N/A
N/A
T. Rowe Price Intl Disciplined Eq Adv
RPNRX13.26N/A
N/A
RiverPark/Next Century Lg Gr Retl

ZBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBIO has been loosely correlated with REPL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBIO jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBIO
1D Price
Change %
ZBIO100%
+1.84%
REPL - ZBIO
40%
Loosely correlated
-3.21%
KURA - ZBIO
32%
Poorly correlated
+2.29%
SNDX - ZBIO
31%
Poorly correlated
+0.23%
CRNX - ZBIO
31%
Poorly correlated
+1.07%
IMNM - ZBIO
31%
Poorly correlated
-1.61%
More